Company / R&D Expense
CV Sciences, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$122.0K
FY2025
5-year range
$118.0K / $1.2M
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense returned to growth in FY2025 after 5 years of decline, reaching $122,000.
Based on SEC 10-K filings.
$122,000 in FY2025 with a 5-year CAGR of -47.1%.
Declined from $151,000 to $122,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -26.5%
- 5-Year CAGR
- -47.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -47.1%, indicating a declining trend.
- In FY2025, r&d expense increased 3.4% year-over-year.
- Peak r&d expense was recorded in FY2019.
- Lowest r&d expense in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.81 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $122.0K | +3.4% |
| FY2024 | $118.0K | -21.9% |
| FY2023 | $151.0K | -50.8% |
| FY2022 | $307.0K | -74.1% |
| FY2021 | $1.2M | -59.7% |
| FY2020 | $2.9M | -49.9% |
| FY2019 | $5.9M | +211.8% |
| FY2018 | $1.9M | +160.4% |
| FY2017 | $724.0K | -37.5% |
| FY2016 | $1.2M | -12.2% |